SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000919574-21-002101
Filing Date
2021-02-26
Accepted
2021-02-26 16:24:47
Documents
1

Document Format Files

Seq Description Document Type Size
1 d8808984_13g.htm SC 13G 121921
  Complete submission text file 0000919574-21-002101.txt   123712
Mailing Address 540 MADISON AVENUE 7TH FLOOR NEW YORK NY 10022
Business Address 540 MADISON AVENUE 7TH FLOOR NEW YORK NY 10022 2127025204
SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by) CIK: 0001569064 (see all company filings)

IRS No.: 453704500 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 130 WEST 42ND STREET 26TH FLOOR NEW YORK NY 10036
Business Address 130 WEST 42ND STREET 26TH FLOOR NEW YORK NY 10036 877-746-4891
Sio Gene Therapies Inc. (Subject) CIK: 0001636050 (see all company filings)

IRS No.: 981333697 | Fiscal Year End: 0331
Type: SC 13G | Act: 34 | File No.: 005-88883 | Film No.: 21689325
SIC: 2834 Pharmaceutical Preparations